Search

Your search keyword '"M Katayama"' showing total 1 results
Start Over Author "M Katayama" Region tokyo

Refine your results

1 results on '"M Katayama"'

1. Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.

Author

Mori N, Katayama M, and Nukaga S

Subjects
Aged, COVID-19 epidemiology, Drug Therapy, Combination, Female, Humans, Liver drug effects, Male, Middle Aged, SARS-CoV-2 drug effects, Tokyo epidemiology, Antiviral Agents therapeutic use, Azithromycin therapeutic use, Hydroxychloroquine therapeutic use, Pregnenediones therapeutic use, COVID-19 Drug Treatment
Abstract

No specific therapy is available for COVID-19. We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy., Competing Interests: Declaration of competing interest All authors do not have any conflicts of interest to declare., (Copyright © 2020. Published by Elsevier B.V.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results